Occudo Quantitative Strategies LP Bio Atla, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.3 - $8.25 $49,953 - $179,181	21,719 New	21,719 $58,000
Q3 2022 Nov 14, 2022	SELL	$2.94 - $11.87 $73,270 - $295,824	-24,922 Reduced 55.62%	19,885 $153,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $5.38 $150,471 - $380,064	-70,644 Reduced 61.19%	44,807 $128,000
Q1 2022 May 16, 2022	BUY	$4.38 - $18.78 $505,675 - $2.17 Million	115,451 New	115,451 $577,000

23.4M

30.8K

57K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $10.2M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.